Tejnaksh Healthcare Ltd

A sharp decline in Tejnaksh Healthcare Ltd has pushed the stock to a fresh 52-week low of Rs 10.65 on 27 Mar 2026, marking a near 57% drop from its peak of Rs 24.77 within the last year. This downturn comes amid a broader market weakness, but the stock’s underperformance far exceeds that of the benchmark indices, signalling company-specific pressures.

Tejnaksh Healthcare Ltd’s share price declined to a fresh 52-week low of ₹11.25 on 23 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed both its sector and broader market indices, reflecting persistent challenges in its financial and market performance.

Tejnaksh Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 20 March 2026, reflecting deteriorating technical indicators, stagnant financial performance, and persistent valuation concerns. The micro-cap healthcare services company’s Mojo Score has declined to 26.0, signalling heightened risk for investors amid ongoing underperformance relative to benchmarks and peers.

Despite a broadly positive market environment, Tejnaksh Healthcare Ltd has slipped to a fresh 52-week low of Rs 12 on 20 Mar 2026, extending its recent downward trajectory amid persistent underperformance and valuation concerns.

Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 12 March 2026, driven primarily by a shift in technical indicators. Despite this improvement, the healthcare services micro-cap continues to face challenges in financial performance and long-term fundamentals, underscoring a cautious outlook for investors.

Tejnaksh Healthcare Ltd’s shares touched a fresh 52-week low of Rs.12.1 today, marking a significant milestone in the stock’s ongoing decline. The healthcare services company has seen its share price fall sharply over the past year, reflecting persistent challenges in its financial performance and market positioning.

Tejnaksh Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 9 February 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite a very attractive valuation, the company’s flat financial performance, declining profitability, and bearish technical trends have prompted a reassessment of its outlook within the Healthcare Services sector.

Tejnaksh Healthcare Ltd., a Mumbai-based speciality urology hospital operator, reported a consolidated net profit of ₹0.30 crores for Q3 FY26, marking a sharp 50.82% decline year-on-year from ₹0.61 crores in Q3 FY25. The micro-cap company, with a market capitalisation of ₹32.00 crores, witnessed its third consecutive quarter of revenue contraction, raising concerns about operational sustainability in an otherwise resilient healthcare services sector.

Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing challenges in financial performance and valuation metrics. The company’s technical trend has improved from bearish to mildly bearish, prompting a reassessment of its market stance. However, fundamental weaknesses and valuation concerns continue to weigh on investor sentiment.

Tejnaksh Healthcare Ltd’s shares declined sharply to a fresh 52-week low of Rs.12.55 on 27 Jan 2026, marking a significant milestone in the stock’s downward trajectory amid broader market weakness and company-specific performance concerns.

Tejnaksh Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 2 January 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The healthcare services company’s Mojo Score improved to 31.0, reflecting a nuanced market view that balances technical recovery against ongoing financial underperformance and valuation considerations.

Tejnaksh Healthcare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 03 Dec 2025. However, all fundamentals, returns, and financial metrics discussed below reflect the stock’s current position as of 26 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Tejnaksh Healthcare’s shares reached a fresh 52-week low of Rs.14.01 today, marking a significant decline amid ongoing challenges in the healthcare services sector. The stock’s performance continues to trail behind key market indices and sector benchmarks, reflecting persistent pressures on the company’s financial metrics and valuation.

Tejnaksh Healthcare has reached a new 52-week low, with its share price touching Rs.15.15 today. This marks a significant decline for the healthcare services company amid broader market fluctuations and ongoing performance concerns.